-
Story /Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
-
Story /The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story /Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
-
Story /Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
-
Story /Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.
-
Story / -
Story /Novel digital platform for clinical trial data collection could help facilitate much-needed biomedical research in lower-income countries.
-
Story /Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
-
Story /New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.